Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease - Isakova, T; Xie, H; Yang, WChronic Renal Insufficiency Cohort (CRIC) Study Group (JAMA, 2011)
et al.